NewGenIvf (NIVF) Income towards Parent Company (2024 - 2025)
NewGenIvf (NIVF) posted quarterly Income towards Parent Company of -$7.7 million for Q4 2025, down 1322.06% year-over-year from $631498.7 in Q4 2024, and down 146.08% quarter-over-quarter from $16.7 million in Q3 2025.
NewGenIvf (NIVF) Income towards Parent Company (2024 - 2025) Analysis & Trends
NewGenIvf (NIVF) has reported Income towards Parent Company for 2 consecutive years, with -$7.7 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Income towards Parent Company fell 1322.06% year-over-year to -$7.7 million; the TTM figure through Dec 2025 stood at $8.5 million (up 1581.26% YoY), while the FY2025 annual figure was $8.0 million, up 1062.8% from the prior year.
- Income towards Parent Company retreated to -$7.7 million in Q4 2025 per NIVF's latest filing, from $16.7 million in the prior quarter.
- Across five years, Income towards Parent Company topped out at $16.7 million in Q3 2025 and bottomed at -$7.7 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | HCA Healthcare | 88.19 Bn | 90.61 Bn | 15.19 Bn |
| 2 | Tenet Healthcare | 21.59 Bn | 21.56 Bn | 4.45 Bn |
| 3 | Encompass Health | 12.19 Bn | 12.86 Bn | 1.34 Bn |
| 4 | Davita | 11.52 Bn | 12.39 Bn | 1.16 Bn |
| 5 | Ensign | 10.59 Bn | 10.27 Bn | 306.24 Mn |
| 6 | Universal Health Services | 8.79 Bn | 8.72 Bn | 3.29 Bn |
| 7 | Pacs | 7.04 Bn | 6.88 Bn | 338.46 Mn |
| 8 | Chemed | 6.96 Bn | 6.92 Bn | 221.47 Mn |
| 9 | Concentra Group Holdings Parent | 4.52 Bn | 4.38 Bn | 192.10 Mn |
| 10 | NewGenIvf | 9,048.24 | -1.43 Mn | 524,025.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -7.72 Mn |
| Sep 30, 2025 | 16.75 Mn |
| Dec 31, 2024 | -542,684.00 |
| Sep 30, 2024 | -30,342.00 |